Table 1 Baseline Characteristics
Characteristics | Early-RFA (N = 96) (No, %; Mean ± SD) | Late-RFA (N = 34) (No, %; Mean ± SD) | P value |
|---|---|---|---|
Gender | Â | Â | 0.67 |
Male | 82 (85.4%) | 28 (82.4%) | Â |
Female | 14 (14.6%) | 6 (17.6%) | Â |
Age (years) | 55.53 ± 10.4 | 54.18 ± 11.1 | 0.52 |
Bilirubin (µmol/L) | 20.3 ± 13.4 | 20.1 ± 11.8 | 0.94 |
Albumin (g/L) | 37.8 ± 6.0 | 38.0 ± 5.4 | 0.87 |
PT(s) | 14.3 ± 1.7 | 14.0 ± 1.6 | 0.31 |
AST (µmol/L) | 48.0 ± 32.4 | 37.6 ± 29.9 | 0.11 |
Maximal tumor diameter (cm) | Â | Â | 0.08 |
Mean ± SD | 4.0 ± 2.8 | 5.0 ± 2.7 |  |
Range | 1.1–15.6 | 1.9–12.8 |  |
1–3 cm | 44 (45.8%) | 12 (35.3%) |  |
3.1–5 cm | 30 (31.3) | 12 (35.3%) |  |
5.1–10 cm | 17 (17.7%) | 8 (23.5%) |  |
 > 10 cm | 5 (5.2%) | 2 (5.9%) |  |
No. of tumors | Â | Â | 0.20 |
Mean ± SD | 1.18 ± 0.5 | 1.29 ± 0.5 |  |
1 | 82 (85.4%) | 24 (70.6%) | Â |
2–3 | 14 (14.6%) | 10 (29.4%) |  |
Hepatitis | Â | Â | 0.56 |
Hepatitis B | 83 (86.5%) | 28 (82.4%) | Â |
Other | 13 (13.5%) | 6 (17.6%) | Â |
α-Fetoprotein level |  |  | 0.95 |
 > 400 ng/mL | 26 (27.1%) | 9 (26.5%) |  |
 ≤ 400 ng/ml | 70 (72.9%) | 25 (73.5%) |  |
Child–Pugh score |  |  | 0.67 |
A | 82 (85.4%) | 28 (82.4%) | Â |
B | 14 (14.6%) | 6 (17.6%) | Â |
BCLC | Â | Â | 0.17 |
A | 44 (45.8%) | 11 (32.4%) | Â |
B | 52 (54.2%) | 23 (67.6%) | Â |
TACE sessions | 3.21 ± 2.6 | 5 ± 2.1 | 0.00 |